Ionis will be presenting at upcoming investor conferences on Investing.com

CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ — Ionis Pharmaceuticals (NASDAQ:), Inc. (Nasdaq: IONS) today announced that executives will participate in heated discussions at the following investor conferences:

• Residences at the Guggenheim First Healthcare Conference to Wednesday, November 13, 2024
• UBS Global Healthcare Conference to Wednesday, November 13, 2024
• Stifel 2024 Healthcare Conference on Monday (NASDAQ:), November 18, 2024
• Jefferies London Healthcare Conference to Wednesday, November 20, 2024
• Citi’s 2024 Global Healthcare Conference on Tuesday, December 3, 2024
• Piper Sandler 36^th The Annual Health Care Conference is open Wednesday, December 4, 2024

Live webcasts of these presentations can be accessed on the Investors & Media section of the Ionis website Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has developed medicines that bring a better future to people with serious illnesses. Ionis currently has five marketed drugs and a leading pipeline in neurology, cardiology, and other areas of high patient demand. As the inventor of RNA-directed medicine, Ionis continues to innovate RNA therapies in addition to developing new methods of gene editing. A deep understanding of disease biology and industry-leading technologies drive our work, coupled with a passion and urgency to deliver breakthroughs that change patients’ lives.

To learn more about Ionis, visit Ionis.com and follow us X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact: D. Wade WalkePh.D. ” ir@ionis.com ” 760-603-2331

Ionis Pharmaceuticals Media Contact: Hayley Soffer ” media@ionis.com ” 760-603-4679